HYGEIA HEALTHCARE HO

6078
Delayed Quote. Delayed  - 08/16 04:08:49 am
44HKD -1.23%
Valuation
Fiscal Period: December 2021 2022
Capitalization1 24 57323 500
Enterprise Value (EV)2 25 09823 491
P/E ratio 56,0x37,9x
Yield -0,10%
Capitalization / Revenue 10,6x7,15x
EV / Revenue 10,8x7,15x
EV / EBITDA 35,4x22,9x
Price to Book 5,51x4,75x
Nbr of stocks (in thousands) 618 000616 724
Reference price (CNY) 39,838,1
Announcement Date 03/30/2022-
Previous period Next period
1 HKD in Million
2 CNY in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2021 2022
Net sales1 2 3153 285
EBITDA1 7081 026
Operating profit (EBIT)1 594805
Operating Margin 25,6%24,5%
Pre-Tax Profit (EBT)1 573801
Net income1 441610
Net margin 19,1%18,6%
EPS2 0,711,01
Dividend per Share2 -0,04
Announcement Date 03/30/2022-
Previous period Next period
1 CNY in Million
2 CNY
Estimates
Finances - Leverage
Fiscal Period: December 2021 2022
Net Debt1 525-
Net Cash position1 -9,02
Leverage (Debt / EBITDA) 0,74x-0,01x
Free Cash Flow1 -243522
ROE (Net Profit / Equities) 10,1%13,1%
Shareholders' equity1 4 3624 655
ROA (Net Profit / Asset) 7,75%9,15%
Assets1 5 6946 666
Book Value Per Share2 7,218,02
Cash Flow per Share2 0,691,02
Capex1 669429
Capex / Sales 28,9%13,1%
Announcement Date 03/30/2022-
Previous period Next period
1 CNY in Million
2 CNY
Estimates
Financial Ratios
Size 2022e 2023e
Capitalization 23 500 M CNY -
Enterprise Value (EV) 23 491 M CNY 22 860 M CNY
Valuation 2022e 2023e
P/E ratio (Price / EPS) 37,9x 28,7x
Capitalization / Revenue 7,15x 5,61x
EV / Revenue 7,15x 5,61x
EV / EBITDA 22,9x 18,2x
Yield (DPS / Price) 0,10% 0,18%
Price to book (Price / BVPS) 4,75x 4,10x
Profitability 2022e 2023e
Operating Margin (EBIT / Sales) 24,5% 25,0%
Operating Leverage (Delta EBIT / Delta Sales) 0,85x 1,09x
Net Margin (Net Profit / Revenue) 18,6% 19,3%
ROA (Net Profit / Asset) 9,15% 11,4%
ROE (Net Profit / Equities) 13,1% 15,2%
Rate of Dividend 3,98% 5,27%
Balance Sheet Analysis 2022e 2023e
CAPEX / Sales   13,1% 9,86%
Cash Flow / CA 19,1% 24,2%
Capital Intensity (Assets / Revenue) 2,03x 1,70x
Financial Leverage (Net Debt / EBITDA) - -
Price Earning Ratio
Change in Enterprise Value/EBITDA
EPS & Dividend